Assyro AI

FDA Orange Book · active-ingredient family

Hydrocortisone valerate

Hydrocortisone valerate is approved as 2 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:WESTCORT · NDA 018726

2

Brand (NDA)

11

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, ointment

ProductApplicantApplicationTEApproved
WESTCORTRLDSUN PHARM INDS INCNDA 018726Aug 08, 1983
WESTCORTRLDSUN PHARM INDS INCNDA 017950Approved Prior to Jan 1, 1982

Generic (ANDA) products (11)

ProductApplicantApplicationTEApproved
HYDROCORTISONE VALERATEENCUBE ETHICALSANDA 211047ABNov 04, 2021
HYDROCORTISONE VALERATECOSETTE PHARMS NCANDA 213724ABFeb 11, 2021
HYDROCORTISONE VALERATECOSETTE PHARMS NCANDA 211764ABMar 04, 2020
HYDROCORTISONE VALERATELUPINANDA 210307ABAug 15, 2019
HYDROCORTISONE VALERATEGLENMARK PHARMS LTDANDA 211750Dec 14, 2018
HYDROCORTISONE VALERATEGLENMARK PHARMS LTDANDA 211129Oct 12, 2018
HYDROCORTISONE VALERATEFOUGERA PHARMSANDA 075085Jul 31, 2001
HYDROCORTISONE VALERATEPADAGIS ISRAELANDA 075666May 24, 2000
HYDROCORTISONE VALERATESUN PHARMA CANADAANDA 075042ABAug 25, 1998
HYDROCORTISONE VALERATESUN PHARMA CANADAANDA 075043ABAug 25, 1998
HYDROCORTISONE VALERATECOSETTEANDA 074489Aug 12, 1998

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Hydrocortisone valerate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.